Unknown

Dataset Information

Elaborate biologic approval process delays care of patients with moderate-to-severe asthma.


ABSTRACT:

Background

mAbs (biologics) are indicated in patients with poorly controlled moderate-to-severe asthma. The process of prior authorization and administration of a biologic requires exceptional commitment from clinical teams.

Objective

Our aim was to evaluate the process of approval and administration of biologics for asthma and determine the most common reasons associated with denials of biologics and delays in administration.

Methods

We examined the records of patients with asthma who were prescribed biologics from January 2018 to January 2020 at 2 centers, Montefiore Medical Center (Bronx, NY) and Scripps Clinics (San Diego, Calif). Demographics, insurance information, and details on the approval process were collected.

Results

After querying of electronic he

SUBMITTER: Sehanobish E 

PROVIDER: S-EPMC10509902 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature